- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | iSpecimen Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| ISPECIMEN Aktie jetzt für 0€ handeln | |||||
| Di | iSpecimen gibt Änderungen im Vorstand und neue Direktorenernennung bekannt | 1 | Investing.com Deutsch | ||
| Di | iSpecimen Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.06. | iSpecimen Inc. - S-1/A, General form for registration of securities | 10 | SEC Filings | ||
| 05.06. | iSpecimen Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.05. | iSpecimen Inc. - S-1/A, General form for registration of securities | 4 | SEC Filings | ||
| 19.05. | iSpecimen Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.05. | iSpecimen Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 4 | SEC Filings | ||
| 02.05. | iSpecimen Inc. - S-1, General form for registration of securities | 2 | SEC Filings | ||
| 14.04. | iSpecimen Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 26.03. | iSpecimen Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 11.03. | iSpecimen Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.02. | iSpecimen Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | iSpecimen Inc.: iSpecimen Secures Suppliers for COVID-style hMPV Outbreak | 456 | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - January 16, 2025) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, has secured suppliers for the flu-like human metapneumovirus... ► Artikel lesen | |
| 16.01. | iSpecimen Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.12.24 | iSpecimen Inc.: iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens | 403 | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - December 20, 2024) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, today announced its strategic initiatives for 2025... ► Artikel lesen | |
| 13.12.24 | Pre-market Movers: Loop Industries, Repare Therapeutics, Candel Therapeutics, Inovio Pharmaceuticals, iSpecimen | 977 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green Loop Industries, Inc. (LOOP) is up over 56% at $1.93.
iSpecimen... ► Artikel lesen | |
| 13.12.24 | iSpecimen Inc.: iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers | 345 | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - December 13, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens... ► Artikel lesen | |
| 12.12.24 | iSpecimen Inc.: iSpecimen Appoints Robert Lim as CEO and Director | 562 | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - December 12, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens... ► Artikel lesen | |
| 08.11.24 | iSpecimen Inc.: iSpecimen Named Top Competitor in $4.4 Billion USD Market | 323 | Newsfile | Woburn, Massachusetts--(Newsfile Corp. - November 8, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ILLUMINA | 80,30 | -0,91 % | Code des Lebens entschlüsselt - so geht es weiter! Illumina, PanGenomic Health, Moderna | Erbinformationen sind die Baupläne des Lebens. Schon heute lassen sich mit Hilfe der Genomsequenzierung Informationen gewinnen, die unser Leben verlängern. Das gilt etwa, wenn wir bestimmte Vorprägungen... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 40,600 | 0,00 % | CRISPR Therapeutics AG: CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310 Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline | -New Phase 1 clinical data for CTX310 continues to demonstrate dose-dependent reductions in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 86%... ► Artikel lesen | |
| INTELLIA THERAPEUTICS | 8,366 | +2,50 % | CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential? | ||
| EDITAS MEDICINE | 1,924 | -1,00 % | Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? | ||
| NEUROCRINE BIOSCIENCES | 108,55 | +1,26 % | Neurocrine Biosciences, Inc.: Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA (valbenazine) Capsules in Older Adults with Tardive ... | Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia
Findings... ► Artikel lesen | |
| ARROWHEAD PHARMACEUTICALS | 13,400 | -2,40 % | Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results | PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting... ► Artikel lesen | |
| GALAPAGOS NV | 24,160 | +1,00 % | Galapagos NV: Galapagos Appoints Aaron Cox as Chief Financial Officer | Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership
Mechelen, Belgium; June 23, 2025, 07:30 CET; regulated... ► Artikel lesen | |
| CARDIFF ONCOLOGY | 2,695 | +0,56 % | Cardiff Oncology, Inc. - 8-K, Current Report | ||
| TWIST BIOSCIENCE | 31,300 | +1,95 % | Cathie Wood setzt wieder auf Nvidia, auch TSMC wandert verstärkt ins Portfolio, mit Twist Bioscience wird eine Wette eingegangen und Palantir scheint der Investorin zu heiß geworden | Die Börse wird oft als seriöser und kühler Ort angesehen, doch sind die Handelsplätze längst nicht frei von Emotionen. Auch hier gibt es prominente Investorinnen und Investoren, die teils wie Popsternchen... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,030 | -6,85 % | Recursion Pharmaceuticals: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing... ► Artikel lesen | |
| REPLIGEN | 104,50 | -1,04 % | What Analysts Are Saying About Repligen Stock | ||
| ROCKET PHARMACEUTICALS | 2,169 | +0,93 % | ROCKET PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| XBIOTECH | 2,460 | +1,65 % | XBiotech beruft Thomas Kündig und Craig Rademaker in den Vorstand | ||
| PERSONALIS | 5,450 | -3,28 % | Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue | FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and... ► Artikel lesen | |
| SPERO THERAPEUTICS | 2,500 | -0,79 % | Alleviating the Pain of CRPS Gave Heather Her Life Back: The Spero Clinic's Role in the Recovery | Is it possible that a simple sound can hurt you? That the sound of a bird singing in the yard can make you scream out in pain? That's the reality of having CRPS. Here's how the Spero Clinic helped Heather... ► Artikel lesen |
ISPECIMEN INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von -0,004 (-0,41 %) liegt der Kurs bei 0,950 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ISPECIMEN INC finden Sie auf Wallstreet Online.